Sławomira Kyrcz-Krzemień

Author PubWeight™ 4.27^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Idiopathic, asymptomatic, and durable blood hypereosinophilia-still many unknowns.	J Allergy Clin Immunol	2014	1.08
2	Occurrence of secondary malignancies in chronic myeloid leukemia during therapy with imatinib mesylate-single institution experience.	Mediterr J Hematol Infect Dis	2015	0.83
3	New drugs in multiple myeloma - role of carfilzomib and pomalidomide.	Contemp Oncol (Pozn)	2014	0.82
4	Autologous stem cell transplantation for mantle cell lymphoma - single centre experience.	Contemp Oncol (Pozn)	2013	0.78
5	Role of Donor Activating KIR-HLA Ligand-Mediated NK Cell Education Status in Control of Malignancy in Hematopoietic Cell Transplant Recipients.	Biol Blood Marrow Transplant	2015	0.76
6	Quality of Life and Adherence to Therapy in Patients With Chronic Myeloid Leukemia Treated With Nilotinib as a Second-Line Therapy: A Multicenter Prospective Observational Study.	Clin Lymphoma Myeloma Leuk	2017	0.75
7	Is it time for erythropoietin use in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients?	Chin Clin Oncol	2012	0.75